Overview

The Double Marker Test is a pivotal prenatal screening procedure conducted during pregnancy to assess the risk of chromosomal abnormalities in the foetus, particularly Down syndrome and trisomy 18. Srinivasa Hospital with advanced facilities and expertise, are primary centres where this crucial test is administered to expectant mothers.

Typically recommended between the 10th and 14th weeks of pregnancy, the Double Marker Test combines two aspects: a blood test and an ultrasound. The blood test measures levels of two specific proteins: free beta-hCG and PAPP-A. The ultrasound, often termed the nuchal translucency scan, gauges the fluid accumulation at the back of the foetal neck.

We have state-of-the-art equipment and highly qualified obstetricians who ensure the accuracy and reliability of results. They monitor for any deviations from the normal range in these markers as it can indicate a potential risk, prompting further detailed investigations.

Additionally, we also provide comprehensive counselling to discuss the results with expectant parents, explaining the findings and recommending subsequent steps, which may include more specific diagnostic tests.